1
TÍTULO: Expected HIV-1 etravirine resistance after treatment failure with efavirenz and/or nevirapine
AUTORES: Beheydt, G; Vercauteren, J; Levy, I; Rudich, H; Ram, D; Carvalho, AP; Van Laethem, K; Vandamme, AM; Camacho, R; Grossman, Z;
PUBLICAÇÃO: 2010, FONTE: Workshop on International HIV and Hepatitis Virus Drug Resistance and Curative Strategies in ANTIVIRAL THERAPY, VOLUME: 15
INDEXADO EM: WOS
2
TÍTULO: Expected HIV-1 etravirine resistance after treatment failure with efavirenz and/or nevirapine
AUTORES: Beheydt, G; Vercauteren, J; Levy, I; Rudich, H; Ram, D; Carvalho, AP; Van Laethem, K; Vandamme, AM; Camacho, R; Grossman, Z;
PUBLICAÇÃO: 2010, FONTE: International HIV and Hepatitis Virus Drug Resistance and Curative Strategies Workshop in ANTIVIRAL THERAPY, VOLUME: 15, NÚMERO: 4
INDEXADO EM: WOS
3
TÍTULO: Bayesian network analysis of resistance pathways against HIV-1 protease inhibitors  Full Text
AUTORES: Deforche, K; Camacho, R; Grossman, Z; Silander, T; Soares, MA; Moreau, Y; Shafer, RW; Van Laethem, K; Carvalho, AP; Wynhoven, B; Cane, P; Snoeck, J; Clarke, J; Sirivichayakul, S; Ariyoshi, K; Holguin, A; Rudich, H; Rodrigues, R; Bouzas, MB; Cahn, P; Brigido, LF; Soriano, V; Sugiura, W; Phanuphak, P; Morris, L; Weber, J; Pillay, D; Tanuri, A; Harrigan, PR; Shapiro, JM; Katzenstein, DA; Kantor, R; Vandamme, AM ; ...Mais
PUBLICAÇÃO: 2007, FONTE: 11th International Workshop on Virus Evolution and Molecular Epidemiology in INFECTION GENETICS AND EVOLUTION, VOLUME: 7, NÚMERO: 3
INDEXADO EM: Scopus WOS CrossRef